Gene · 1573
Papers1,413
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,413
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multiomics characterization of fatty acid metabolism for the clinical management of hepatocellular carcinoma. | Sci Rep | 2023 | 38110715 | PubTator, text mining | PubMed |
| Comprehensive Profiling and Therapeutic Insights into Differentially Expressed Genes in Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 38067357 | PubTator, text mining | PubMed |
| Pharmacogenetic Variation in Neanderthals and Denisovans and Implications for Human Health and Response to Medications. | Genome Biol Evol | 2023 | 38051947 | PubTator, text mining | PubMed |
| Interplay between Vitamin D and Adipose Tissue: Implications for Adipogenesis and Adipose Tissue Function. | Nutrients | 2023 | 38004226 | PubTator, text mining | PubMed |
| Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention. | Biomedicines | 2023 | 38001897 | PubTator, text mining | PubMed |
| Pharmacogenetic Approach for the Prevention of Rivaroxaban's ADRs: A Systematic Review and Meta-Analysis. | Genet Res (Camb) | 2023 | 37942082 | PubTator, text mining | PubMed |
| Computational prognostic evaluation of Alzheimer's drugs from FDA-approved database through structural conformational dynamics and drug repositioning approaches. | Sci Rep | 2023 | 37865690 | PubTator, text mining | PubMed |
| Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration. | Invest Ophthalmol Vis Sci | 2023 | 37862026 | PubTator, text mining | PubMed |
| In vivo evaluation of the pharmacokinetic interactions between almonertinib and rivaroxaban, almonertinib and apixaban. | Front Pharmacol | 2023 | 37860116 | PubTator, text mining | PubMed |
| Coadministration of bedaquiline and pyrifazimine reduce exposure to toxic metabolite N-desmethyl bedaquiline. | Front Pharmacol | 2023 | 37860115 | PubTator, text mining | PubMed |
| The Effects of Bariatric Surgery on Pharmacokinetics of Drugs: a Review of Current Evidence. | Curr Nutr Rep | 2023 | 37857987 | PubTator, text mining | PubMed |
| Meta-analysis of lean and obese RNA-seq datasets to identify genes targeting obesity. | Bioinformation | 2023 | 37808366 | PubTator, text mining | PubMed |
| Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side. | CPT Pharmacometrics Syst Pharmacol | 2023 | 37794718 | PubTator, text mining | PubMed |
| Involvement of multiple cytochrome P450 isoenzymes in drug interactions between ritonavir and direct oral anticoagulants. | Drug Metab Pharmacokinet | 2023 | 37778107 | PubTator, text mining | PubMed |
| Advances in drug resistance of triple negative breast cancer caused by pregnane X receptor. | World J Clin Oncol | 2023 | 37771631 | PubTator, text mining | PubMed |
| Pharmacokinetic and Pharmacogenetic Predictors of Major Bleeding Events in Patients with an Acute Coronary Syndrome and Atrial Fibrillation Receiving Combined Antithrombotic Therapy. | J Pers Med | 2023 | 37763139 | PubTator, text mining | PubMed |
| Vitamin D: An Overview of Gene Regulation, Ranging from Metabolism to Genomic Effects. | Genes (Basel) | 2023 | 37761831 | PubTator, text mining | PubMed |
| LncRNA SNHG6 role in clinicopathological parameters in cancers. | Eur J Med Res | 2023 | 37735423 | PubTator, text mining | PubMed |
| The "outsized" role of the I-helix kink in human Cytochrome P450s. | Clin Transl Med | 2023 | 37712170 | PubTator, text mining | PubMed |
| Interactions between microglia and glioma in tumor microenvironment. | Front Oncol | 2023 | 37700840 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1573/papers?page=5